Search Results 301-310 of 16865 for Humira

  1. Device Evaluation for Point of Care Anticoagulation Testing - Mayo Clinic

    About this study. The purpose of this study is: To Evaluate and validate the Roche Coaguchek XS Plus analyzer at MCA to replace the ITC Hemochron Jr.

  2. A Study to Learn More about How Individuals Process Specific Medications Based on Their Genes in Patients with Gastrointestinal Disorders - Mayo Clinic

    About this study · To evaluate the pharmacogenomic profile (PGx) by genotyping 22 genes, including the CYP2D6 genotype, in patients with functional GI disorders.

  3. Optimizing Health and Performance in Healthcare Workers - Mayo Clinic

    About this study. The purpose of this tudy is to evaluating IM8 Daily Ultimate Essentials vs Placebo. Participation eligibility.

  4. Gastroenterology and Hepatology - Clinical trials

    There is evidence that colonic inflammation plays a major role in colon polyp and colorectal cancer development. For example, inflammatory bowel disease is a ...

  5. Gastroenterology and Hepatology - Clinical trials

    Rochester, Minn. The purpose of this study is to create a registry of obese patients who have been phenotyped to understand the heterogeneity of obesity. Celiac ...

  6. Myelodysplastic syndromes - Doctors and departments - Mayo Clinic

    Learn how medications and bone marrow transplants are used to control complications caused by these syndromes that affect the bone marrow.

  7. A Study to Evaluate Ramucirumab Plus Trifluridine/Tipiracil to Treat Patients with Previously-treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma - Mayo Clinic

    The purpose of this study is to compare, in a non-inferiority fashion, the progression-free survival (PFS) in patients with metastatic refractory gastric/ ...

  8. A Study to Evaluate the Effectiveness and Safety of Camidanlumab Tesirine (ADCT-301) in Patients with Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

    The purpose of this study is to evaluate the clinical effectiveness and safety of Camidanlumab Tesirine (ADCT-301) in participants with relapsed or refractory ...

  9. Study of Tipifarnib in Subjects With Relapsed or Refractory Peripheral T-Cell Lymphoma - Mayo Clinic

    Tipifarnib will be administered until disease progression then followed approximately every 12 weeks for survival until either death or 12 months after accrual ...

  10. Mayo Clinic’s Hemophilia Treatment Center

    An error occurred, please try again later. Copy for customer care: session ID undefined. Try again. Share · Tweet . VID-20464236.